ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,196,000 | -39.7% | 500,256 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $3,643,000 | +64.1% | 501,739 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $2,220,000 | +7.1% | 513,801 | +1.9% | 0.00% | 0.0% |
| Q3 2020 | $2,073,000 | -33.1% | 504,313 | -2.4% | 0.00% | 0.0% |
| Q2 2020 | $3,100,000 | -17.4% | 516,701 | +3.7% | 0.00% | -50.0% |
| Q1 2020 | $3,753,000 | -46.5% | 498,391 | -2.3% | 0.00% | -33.3% |
| Q4 2019 | $7,012,000 | +15.8% | 509,979 | +0.0% | 0.00% | +50.0% |
| Q3 2019 | $6,057,000 | -15.4% | 509,827 | -0.4% | 0.00% | -33.3% |
| Q2 2019 | $7,160,000 | -9.3% | 511,800 | +15.9% | 0.00% | 0.0% |
| Q1 2019 | $7,893,000 | +13.6% | 441,423 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $6,948,000 | – | 441,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |